MEZOFY
LaunchSMaripiprazole
NDAORALFILM
Approved
Apr 2025
Lifecycle
Launch
Competitive Pressure
0/100
Clinical Trials
20
Clinical Trials (5)
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)
Started Nov 2021
200 enrolled
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Started Dec 2019
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
Started Aug 2019
266 enrolled
SchizophreniaBipolar I Disorder
DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole
Started Apr 2019
46 enrolled
SchizophreniaMajor Depressive DisorderBi-Polar Disorder+1 more
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
Started Jan 2019
72 enrolled
SchizophreniaBipolar I Disorder
Loss of Exclusivity
LOE Date
Aug 7, 2033
90 months away
Patent Expiry
Aug 7, 2033
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9694008 | Aug 7, 2033 | Product | — |